Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating muscular atrophy

A muscle atrophy and drug technology, applied in the field of medicine, to achieve the effect of improving self-immunity and good curative effect

Inactive Publication Date: 2015-07-01
吴旭
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Clinically, due to the lack of exact understanding of the etiology and pathogenesis of muscle atrophy, there is no effective treatment and patent medicine in Chinese and Western medicine that can cure or prevent the development of this disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0008] Embodiment 1, a kind of medicine for the treatment of muscular atrophy, said material is composed by weight: 15 parts of Angelica sinensis, 15 parts of Sanqi, 10 parts of Bupleurum, 12.5 parts of Lycium barbarum, 9 parts of antlers, 13 parts of Passepartout, 7 parts of pungent, 9 parts of tangerine peel, 12.5 parts of salvia miltiorrhiza, 14 parts of Chuan Achyranthes bidentata; the medicines are prepared into granules, capsules or decoctions according to conventional preparation techniques.

Embodiment 2

[0009] Embodiment 2, a kind of medicine for the treatment of muscular atrophy, said material is composed by weight: 20 parts of Angelica sinensis, 20 parts of Panax notoginseng, 12 parts of Bupleurum, 15 parts of Lycium barbarum, 12 parts of antlers, 15 parts of Passepartout, 9 parts of pungent, 10 parts of tangerine peel, 15 parts of salvia miltiorrhiza, 18 parts of Chuan Achyranthes bidentata; the medicines are prepared into granules, capsules or decoctions according to conventional preparation techniques.

Embodiment 3

[0010] Embodiment 3, a kind of medicine for the treatment of muscular atrophy, said material is composed by weight: 20 parts of Angelica sinensis, 20 parts of Panax notoginseng, 12 parts of Bupleurum, 15 parts of Lycium barbarum, 12 parts of antlers, 15 parts of Passepartout, 9 parts of pungent, 10 parts of tangerine peel, 15 parts of salvia miltiorrhiza, 18 parts of Chuan Achyranthes bidentata; the medicines are prepared into granules, capsules or decoctions according to conventional preparation techniques.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, and particularly relates to a drug for treating muscular atrophy. The drug is composed of the components in parts by weight: 10-20 parts of angelica sinensis, 10-20 parts of pseudo-ginseng, 8-12 parts of radix bupleuri, 10-15 parts of medlar, 6-12 parts of antler, 11-15 parts of beautiful sweetgum fruit, 5-9 parts of asarum sieboldii, 8-10 parts of pericarpium citri reticulatae, 10-15 parts of radix salviae miltiorrhizae, and 10-18 parts of radix cyathulae. The invention aims to provide the drug for treating muscular atrophy, wherein the drug is good in curative effect and improves the human body immunity.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating muscle atrophy. Background technique [0002] Clinically, because there is no definite understanding of the etiology and pathogenesis of muscular atrophy, there is no effective therapy and patent medicine in Chinese and Western medicine that can radically cure or prevent the development of this disease. Contents of the invention [0003] The purpose of the present invention is to provide a medicine for treating muscular atrophy with good curative effect and improving human body's self-immunity. [0004] The technical scheme adopted in the present invention is a medicine for treating muscle atrophy, and the materials are composed by weight: 10-20 parts of Angelica sinensis, 10-20 parts of Radix Notoginseng, 8-12 parts of Bupleuri, 10-15 parts of Lycium barbarum, 6-12 parts of antlers, 11-15 parts of Passepartout, 5-9 parts of Asarum, 8-10 parts of tange...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/815A61P21/00A61K35/32
Inventor 吴旭
Owner 吴旭
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com